Allogeneic split-skin grafting in stem cell transplanted patients.

Area of Science:

• Hematology
• Immunology
• Dermatology

Background:

• Bone marrow transplantation (BMT) is a critical treatment for hematologic malignancies and other conditions.
• Cutaneous chronic Graft versus Host Disease (cGvHD) is a significant post-BMT complication, often leading to severe skin issues like ulcerations.
• Allogeneic skin grafts are typically rejected due to immune system incompatibility.

Observation:

• A patient with myelodysplasia and non-Hodgkin's lymphoma underwent BMT from a sibling donor, achieving complete chimerism.
• The patient developed severe cGvHD, resulting in extensive scalp ulceration.
• An allogeneic split-thickness skin graft (STSG) from the BMT donor was successfully transplanted to the ulcerated scalp.

Findings:

• The allogeneic STSG achieved full and permanent engraftment, persisting for three years.
• This demonstrates that a BMT recipient with stable donor chimerism does not recognize the donor's skin as foreign.
• This challenges the conventional understanding of allogeneic skin graft rejection.

Implications:

• This approach offers a potential solution for managing large skin defects in BMT patients with cGvHD.
• Advances in BMT are increasing long-term survival, making such complications more prevalent.
• Allogeneic STSG from the BMT donor represents a safe and effective alternative for permanent skin coverage in select BMT patients.